Through the C/EBPβ‐δ‐secretase axis, C/EBPβ binds to enhancers in LMGN gene transcription and acts as a transcription factor, leading to an elevation in δ‐secretase expression, thus expediting the progression of AD. Here, CEBPB is linked to Alzheimer disease.